Google Ad

India, US has nice potential for collaboration in healthcare sector: Indian envoy to US – Home Health Choices

Washington: Indian Ambassador to US Taranjit Singh Sandhu mentioned that India and US have nice potential for collaboration in healthcare comparable to in pharma, primary analysis, vaccines, diagnostics, units, telemedicine, hospital administration, healthcare provides, health-care experience.

Speaking at a digital dialogue titled ‘India-US Partnership in Healthcare & Medical Research digital occasion’, Sandhu mentioned, “The global health emergency has made it clear that ensuring equitable, affordable and timely access to health care products and technologies is a priority for all. The global pharma and healthcare industry bear an outsized responsibility in meeting the current challenge.”

On India-US partnership amid the COVID-19 pandemic, Indian Ambassador mentioned, “Indian pharma companies, which are world leaders in affordable low-cost medicines and vaccines, are also collaborating with US companies in vaccine development, therapeutics and diagnostics. Gilead has entered into licensing agreements with seven Indian companies including Cipla, Jubilant Sciences, Dr. Reddy’s among others to manufacture REMDESIVIR and supply it to more than 127 countries. India has been working with the US private sector in vaccine development. There are at least three ongoing collaborations of Indian and US companies and institutions to co-develop and produce a COVID-19 vaccine.”

He additional mentioned that the US is a worldwide chief in pharmaceutical analysis and improvement and India can study loads from the US to develop its personal pharma innovation ecosystem.

Speaking on the long-standing partnership between India and the US in well being and scientific analysis, he mentioned that the scientists and establishments of each nations have been actively engaged within the trade of data. “COVID 19 Virtual Networks being developed under India-US Science and Technology Endowment Fund (IUSTEF) will allow Indian and US scientists and engineers to carry out joint research activities virtually and leverage current infrastructure and funding mechanisms,” he mentioned.

“The US biopharma industry invested around USD 102 billion in R&D in 2018, higher than any other industry in the US. India has large pool scientists and researchers. In fact, over decades, many Indian doctors, scientists and researchers have come to the United States and distinguished themselves.”

Latest Updates

Related Post